Lots of interesting abstracts and cases were submitted for TCTAP 2024. Below are the accepted ones after a thorough review by our official reviewers. Don’t miss the opportunity to expand your knowledge and interact with authors as well as virtual participants by sharing your opinion in the comment section!
TCTAP A-044
Prognostic Impact of Geriatric Nutritional Risk Index After Endovascular Treatment With Lower Extremity Artery Disease
By Akinori Satake, Toru Niwa, Masahiro Shimoda, Akihiro Suzuki, Yusuke Nakano, Hirohiko Ando, Tetsuya Amano
Presenter
Akinori Satake
Authors
Akinori Satake1, Toru Niwa2, Masahiro Shimoda2, Akihiro Suzuki2, Yusuke Nakano2, Hirohiko Ando2, Tetsuya Amano2
Affiliation
Narita Memorial Hospital, Japan1, Aichi Medical University, Japan2
View Study Report
TCTAP A-044
Other Endovascular Intervention
Prognostic Impact of Geriatric Nutritional Risk Index After Endovascular Treatment With Lower Extremity Artery Disease
Akinori Satake1, Toru Niwa2, Masahiro Shimoda2, Akihiro Suzuki2, Yusuke Nakano2, Hirohiko Ando2, Tetsuya Amano2
Narita Memorial Hospital, Japan1, Aichi Medical University, Japan2
Background
The number of patients with lower extremity artery disease (LEAD) continues to increase. Moreover, the volume of endovascular treatment (EVT) increases accordingly.
On the other hand, malnutrition of LEAD patients is underestimated despite nutritional factors are potentially a correctable parameter.
Geriatric nutritional risk index (GNRI), calculated from serum albumin and the components of the body mass index, is a simple nutritional screening method.
However, it is not well known whether GNRI before EVT affects the prognosis of LEAD patients.
We investigatedwhether GNRI before EVT affects the prognosis of LEAD patients
On the other hand, malnutrition of LEAD patients is underestimated despite nutritional factors are potentially a correctable parameter.
Geriatric nutritional risk index (GNRI), calculated from serum albumin and the components of the body mass index, is a simple nutritional screening method.
However, it is not well known whether GNRI before EVT affects the prognosis of LEAD patients.
We investigatedwhether GNRI before EVT affects the prognosis of LEAD patients
Methods
This study was a single-center, retrospectiveanalysis. Between January 2010 and December 2022, consecutive 130 patientsunderwent the first EVT for LEAD at our hospital.
The patients were dividedinto two groups based on the median GNRI: GNRI ≥ 91 group(n = 68) and GNRI < 91 group (n = 62).
The primaryendpoint was all-cause death, and the secondary endpoints were major amputationand target lesion revascularization (TLR) after EVT.
The patients were dividedinto two groups based on the median GNRI: GNRI ≥ 91 group(n = 68) and GNRI < 91 group (n = 62).
The primaryendpoint was all-cause death, and the secondary endpoints were major amputationand target lesion revascularization (TLR) after EVT.
Results
During the follow-up, 67 patients died after EVT. All-cause mortalitywas significantly higher in GNRI<91 group (P < 0.001).
However, majoramputation and target lesion revascularization rates were not significantlydifferent between the two groups.
However, majoramputation and target lesion revascularization rates were not significantlydifferent between the two groups.
Conclusion
The GNRI before EVT was independently associated with mortality inpatients with LEAD.
We should consider the patient's background including malnutrition before EVT.
We should consider the patient's background including malnutrition before EVT.